Key points are not available for this paper at this time.
Design
Review
AI and big data may accelerate discovery of BP agents; leaves open clinical translation in hypertension.
Due to the massive data sets available for drug candidates, modern drug discovery has advanced to the big data era. Central to this shift is the development of artificial intelligence approaches to implementing innovative modeling based on the dynamic, ...Read More
No takes yet. Share an insight, caveat, or question.
W. S. Peart (1962) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: